Pathology of Invasive Breast Disease

Surgical Clinics of North America

Volumn 93, Issue 2, 2013, Pages 363-392

  Corben, Adriana D ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Adenocarcinomas; Invasive breast disease; Lesions

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ESTROGEN RECEPTOR; PROGESTERONE RECEPTOR;

APOCRINE CARCINOMA; AXILLARY LYMPH NODE; BREAST CANCER; BREAST CARCINOMA; CANCER CLASSIFICATION; CANCER DIAGNOSIS; CANCER GRADING; CANCER INVASION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CLINICAL FEATURE; DIAGNOSTIC KIT; ENCAPSULATED PAPILLARY BREAST CARCINOMA; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; INFLAMMATORY BREAST CANCER; INVASIVE APOCRINE BREAST CARCINOMA; INVASIVE BREAST ADENOID CYSTIC CARCINOMA; INVASIVE CRIBRIFORM BREAST CARCINOMA; INVASIVE MEDULLARY BREAST CARCINOMA; INVASIVE METAPLASTIC CARCINOMA; INVASIVE MICROPAPILLARY BREAST CARCINOMA; INVASIVE MUCINOUS BREAST CARCINOMA; INVASIVE NEUROENDOCRINE CARCINOMA; INVASIVE PAPILLARY BREAST CARCINOMA; INVASIVE SECRETORY BREAST CARCINOMA; MOLECULAR DIAGNOSIS; ONCOGENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TREATMENT RESPONSE; TUMOR VOLUME;

ADENOCARCINOMA, MUCINOUS; ADENOCARCINOMA, PAPILLARY; BREAST NEOPLASMS; CARCINOMA, ADENOID CYSTIC; CARCINOMA, NEUROENDOCRINE; FEMALE; HUMANS; NEOPLASM INVASIVENESS; NEOPLASMS, DUCTAL, LOBULAR, AND MEDULLARY; PROGNOSIS; TUMOR BURDEN; TUMOR MARKERS, BIOLOGICAL;

EID: 84875294853     PISSN: 00396109     EISSN: 15583171     Source Type: Journal    
DOI: 10.1016/j.suc.2013.01.003     Document Type: Review

References (74)

1. Wellings S.R., Jensen H.M., Marcum R.G. An atlas of subgross pathology of the human breast with special reference to possible precancerous lesions. J Natl Cancer Inst 1975, 55:231-273.
2. AJCC. Cancer staging manual. 7th edition. American joint committe on cancer. Chicago: Springer; 2010.
3. Colditz G., Chia K.S. Invasive breast carcinoma: introduction and general features. WHO classification of tumors of the breast 2012, 14-31. 4th edition. S.R. Lakhani, I.O. Ellis, S.J. Schnitt (Eds.).
4. Chen C.L. Hormone replacement therapy in relation to breast cancer. JAMA 2002, 287:734-741.
5. DiCostanzo D. Prognosis in infiltrating lobular carcinoma. An analysis of " classical" and variant tumors. Am J Surg Pathol 1990, 14:12-23.
6. Sastre-Garau X. Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservatory therapy and metastatic patterns. Cancer 1996, 77:113-120.
7. Peiro G. The influence of infiltrating lobular carcinoma on the outcome of patients treated with breast-conserving surgery and radiation therapy. Breast Cancer Res Treat 2000, 59:49-54.
8. Wheeler J.E. Lobular carcinoma of the breast in situ and infiltrating. Pathol Annu 1976, 11:161-188.
9. Azzopardi J.G. Problems in breast pathology 1979, WB Saunders, Philadelphia.
10. Rasbridge S.A. Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J Pathol 1993, 169:245-250.
11. Moll R. Differential loss of E-cadherin expression in infiltrating ductal and lobular carcinomas. Am J Pathol 1993, 143:1731-1742.
12. Palacios J. Anomalous expression of P-cadherin in breast carcinoma. Correlation with E-cadherin expression and pathologic features. Am J Pathol 1995, 146:605-612.
13. Berx G. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 1996, 13:1919-1925.
14. Nishizaki T. Genetic alterations in lobular breast cancer by comparative genomic hybridization. Int J Cancer 1997, 74:513-517.
15. Silverstein M.J. Infiltrating lobular carcinoma. Is it different from infiltrating ductal carcinoma?. Cancer 1994, 73:1673-1677.
16. Rajakariar R. Pathological and biological features of mammographically detected invasive breast carcinomas. Br J Cancer 1995, 71:150-154.
17. Cowan W.K. The pathological and biological nature of screen-detected breast carcinomas: a morphological and immunohistochemical study. J Pathol 1997, 182:29-35.
18. Page D.L. Invasive cribriform carcinoma of the breast. Histopathology 1983, 7:525-536.
19. Venable J.G. Infiltrating cribriform carcinoma of the breast: a distinctive clinicopathologic entity. Hum Pathol 1990, 21:333-338.
20. Rubens J.R. Medullary carcinoma of the breast. Overdiagnosis of a prognostically favorable neoplasm. Arch Surg 1990, 125:601-604.
21. Gaffey M.J. Medullary carcinoma of the breast: interobserver variability in histopathologic diagnosis. Mod Pathol 1995, 8:31-38.
22. Siriaunkgul S. Invasive micropapillary carcinoma of the breast. Mod Pathol 1993, 6:660-662.
23. Luna-More S. Invasive micropapillary carcinoma of the breast. A new special type of invasive mammary carcinoma. Pathol Res Pract 1994, 190:668-674.
24. Paterakos M. Invasive micropapillary carcinoma of the breast: a prognostic study. Hum Pathol 1999, 30:1459-1463.
25. Walsh M.M. Invasive micropapillary carcinoma of the breast: eighty cases of an underrecognized entity. Hum Pathol 2001, 32:583-589.
26. Nassar H. Clinicopathologic analysis of invasive micropapillary differentiation in breast carcinoma. Mod Pathol 2001, 14:836-841.
27. Zekioglu O. Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma. Histopathology 2004, 44(1):18-23.
28. Kaufman M.W. Carcinoma of the breast with pseudosarcomatous metaplasia. Cancer 1984, 53:1908-1917.
29. Oberman H.A. Metaplastic carcinoma of the breast. A clinicopathologic study of 29 patients. Am J Surg Pathol 1987, 11:918-929.
30. Rosen P.P. Low-grade adenosquamous carcinoma. A variant of metaplastic mammary carcinoma. Am J Surg Pathol 1987, 11:351-358.
31. Van Hoeven K.H. Low-grade adenosquamous carcinoma of the breast. A clinicopathologic study of 32 cases with ultrastructural analysis. Am J Surg Pathol 1993, 17:248-258.
32. Drudis T. The pathology of low grade adenosquamous carcinoma of the breast. An immunohistochemical study. Pathol Annu 1994, 29(Pt 2):181-197.
33. Mossler J.A. Apocrine differentiation in human mammary carcinoma. Cancer 1980, 46:2463-2471.
34. Eusebi V. Apocrine carcinoma of the breast. A morphologic and immunocytochemical study. Am J Pathol 1986, 123:532-541.
35. O'Malley F.P. The spectrum of apocrine lesions of the breast. Adv Anat Pathol 2004, 11:1-9.
36. Bussolati G. Chromogranin-reactive endocrine cells in argyrophilic carcinomas (" carcinoids") and normal tissue of the breast. Am J Pathol 1985, 120:186-192.
37. Miremadi A. Neuroendocrine differentiation and prognosis in breast adenocarcinoma. Histopathology 2002, 40:215-222.
38. Sapino A. Is detection of endocrine cells in breast adenocarcinoma of diagnostic and clinical significance?. Histopathology 2002, 40:211-214.
39. Carter D. Intracystic papillary carcinoma of the breast. After mastectomy, radiotherapy or excisional biopsy alone. Cancer 1983, 52(1):14-19.
40. Collins L.C. Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers. Am J Surg Pathol 2006, 30(8):1002-1007.
41. Leal C. Intracystic (encysted) papillary carcinoma of the breast: a clinical, pathological, and immunohistochemical study. Hum Pathol 1998, 29(10):1097-1104.
42. Harris K.P. Treatment and outcome of intracystic papillary carcinoma of the breast. Br J Surg 1999, 86(10):1274.
43. Hill C.B. Myoepithelial cell staining patterns of papillary breast lesions: from intraductal papillomas to invasive papillary carcinomas. Am J Clin Pathol 2005, 123(1):36-44.
44. Krausz T. Secretory carcinoma of the breast in the adults: emphasis on late recurrence and metastasis. Histopathology 1989, 14(1):25-36.
45. Rosen P.P. Secretory carcinoma of the breast. Arch Pathol Lab Med 1991, 115(2):141-144.
46. Tavassoli F.A. Secretory carcinoma of the breast. Cancer 1980, 45(9):2404-2413.
47. Page D.L. Adenoid cystic carcinoma of breast, a special histopathologic type with excellent prognosis. Breast Cancer Res Treat 2005, 93:189-190.
48. Acs G. Microglandular adenosis with transition into adenoid cystic carcinoma of the breast. Am J Surg Pathol 2003, 27:1052-1060.
49. Mastropasqua M.G. Immunoreactivity for c-kit and p63 as an adjunct in the diagnosis of adenoid cystic carcinoma of the breast. Mod Pathol 2005, 18:1277-1282.
50. Azoulay S. KIT is highly expressed in adenoid cystic carcinoma of the breast, a basal-like carcinoma associated with a favorable outcome. Mod Pathol 2005, 18:1623-1631.
51. Lerebours F. Update on inflammatory breast cancer. J Clin Oncol 2005, 7:52-58.
52. Guth U. Noninflammatory breast carcinoma with skin involvement. Cancer 2004, 100:470-478.
53. Jackson A.W. Carcinoma of male breast in association with the Klinefelter syndrome. Br Med J 1965, 1(5429):223-225.
54. Hittmair A.P. Ductal carcinoma in situ (DCIS) in the male breast: a morphologic study of 84 cases of pure DCIS and 30 cases of DCIS associated with invasive carcinoma - a preliminary report. Cancer 1998, 83(10):2139-2149.
55. Ellis I.O. Pathological prognostic factors in breast cancer. II. Histological type. Relationship with survival in a large study with long-term follow-up. Histopathology 1992, 20:479-489.
56. Rosen P.P. Factors influencing prognosis in node-negative breast carcinoma: analysis of 767 T1N0M0/T2N0M0 patients with long-term follow-up. J Clin Oncol 1993, 11:2090-2100.
57. Elston C.W. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 1991, 19:403-410.
58. Page D.L. Histologic grading of breast cancer. Let's do it. Am J Clin Pathol 1995, 103:123-124.
59. Chen Y.Y. Prognostic factors for patients with breast cancers 1 cm and smaller. Breast Cancer Res Treat 1998, 51:209-225.
60. Leitner S.P. Predictors of recurrence for patients with small (one centimeter or less) localized breast cancer (T1a, b N0M0). Cancer 1995, 76:2266-2274.
61. Lee A.K. Lymph node negative invasive breast carcinoma 1 centimeter or less in size (T1a, b N0M0): clinicopathologic features and outcome. Cancer 1997, 79:761-771.
62. Mohammed R.A. Improved methods of detection of lymphovascular invasion demonstrate that it is the predominant method of vascular invasion in breast cancer and has important clinical consequences. Am J Surg Pathol 2007, 31:1825-1833.
63. Fitzgibbons P.L. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000, 124:966-978.
64. Wolf A.C. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 2007, 25:118-145.
65. Hicks D.G. HER2+ breast cancer: review of biologic relevance and optimal use of diagnostic stools. Am J Clin Pathol 2008, 129:263-273.
66. Faverly D.R. Three dimensional imaging of mammary ductal carcinoma in situ: clinical implications. Semin Diagn Pathol 1994, 11(3):193-198.
67. Paik S. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004, 351:2817-2826.
68. Habel L.A. A population-based study of tumor gene expression and risk of breast cancer death among lymph node-negative patients. Breast Cancer Res 2006, 8:R25.
69. van de Vijver M.J. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002, 346:1999-2009.
70. Nuyse M. Validation and clinical utility of a 70-gene prognostic signature of women with node-negative breast cancer. J Natl Cancer Inst 2006, 98:1183-1192.
71. Sorlie T. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001, 98:10869-10874.
72. Sorlie T. Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci U S A 2003, 100:8418-8423.
73. Brenton J.D. Molecular classification and molecular forecasting of breast cancer: ready for clinical application?. J Clin Oncol 2005, 23:7350-7360.
74. Nielsen T.O. Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 2004, 10:5367-5374.